Acetyl-L-Carnitine
Natural health product licensed in Canada
- Licence holder
- Biotics Research Corporation
- NPN or DIN-HM
- 80041758
- Status
- Active licence
- Licence date
- 18 April 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Eau purifiée, Gélatine, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 days |
Uses authorised in Canada
Helps to reduce fatigue. Helps to support cognitive function in the elderly.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Feelings of sleeplessness or overstimulation may occur; discontinue use if feeling persists or worsen. Mild gastrointestinal symptoms (transient nausea, vomiting, abdominal cramps, and diarrhoea) have been reported. Low incidences of seizures have been reported with oral doses in individuals with or without pre-existing seizure disorders.
- Contre-indications
Do not use if you have primary systemic L-carnitine deficiency or secondary L-carnitine deficiency (inborn errors of metabolism) for which supplementation is prescribed/monitored by a health care practitioner.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breast feeding. Consult a health care practitioner prior to use if you have liver or kidney disease or if you have been instructed to follow a low protein diet.
Source
Official Health Canada record, licence 80041758
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.